Cargando…

BRCA1 Antibodies Matter

Breast cancer susceptibility gene 1 (BRCA1) encodes a tumor suppressor that is frequently mutated in familial breast and ovarian cancer patients. BRCA1 functions in multiple important cellular processes including DNA damage repair, cell cycle checkpoint activation, protein ubiquitination, chromatin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jing, Qi, Leilei, Chiang, Huai-Chin, Yuan, Bin, Li, Rong, Hu, Yanfen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375228/ https://www.ncbi.nlm.nih.gov/pubmed/34421362 http://dx.doi.org/10.7150/ijbs.63115

Ejemplares similares

Effects of Radiation Therapy on Breast Epithelial Cells in BRCA1/2 Mutation Carriers
por: Chiang, Huai-Chin, et al.
Publicado: (2015)

BRCA1 deficiency in mature CD8(+) T lymphocytes impairs antitumor immunity
por: Wu, Bogang, et al.
Publicado: (2023)

Association of radiotherapy with preferential depletion of luminal epithelial cells in a BRCA1 mutation carrier
por: Chiang, Huai-Chin, et al.
Publicado: (2012)

BRCA1 mutations attenuate super-enhancer function and chromatin looping in haploinsufficient human breast epithelial cells
por: Zhang, Xiaowen, et al.
Publicado: (2019)

BRCA1-associated R-loop affects transcription and differentiation in breast luminal epithelial cells
por: Chiang, Huai-Chin, et al.
Publicado: (2019)

Gene-Specific Genetic Complementation between Brca1 and Cobra1 During Mouse Mammary Gland Development
por: Chiang, Huai-Chin, et al.
Publicado: (2018)

Phosphorylation of BRCA1 by ATM upon double-strand breaks impacts ATM function in end-resection: A potential feedback loop
por: Qi, Leilei, et al.
Publicado: (2022)

PPARγ inhibition boosts efficacy of PD-L1 Checkpoint Blockade Immunotherapy against Murine Melanoma in a sexually dimorphic manner
por: Wu, Bogang, et al.
Publicado: (2020)

Genetic ablation of adipocyte PD-L1 reduces tumor growth but accentuates obesity-associated inflammation
por: Wu, Bogang, et al.
Publicado: (2020)

BRCA1, Hormone, and Tissue-Specific Tumor Suppression
por: Hu, Yanfen
Publicado: (2008)

Genetic suppression reveals DNA repair-independent antagonism between BRCA1 and COBRA1 in mammary gland development
por: Nair, Sreejith J., et al.
Publicado: (2016)

RNA polymerase II pausing factor NELF in CD8(+) T cells promotes antitumor immunity
por: Wu, Bogang, et al.
Publicado: (2022)

Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer
por: Wu, Bogang, et al.
Publicado: (2018)

BRCA1 Interacting Protein COBRA1 Facilitates Adaptation to Castrate-Resistant Growth Conditions
por: Yun, Huiyoung, et al.
Publicado: (2018)

Autoimmune response to PARP and BRCA1/BRCA2 in cancer
por: Zhu, Qing, et al.
Publicado: (2015)

A Role of CREB in BRCA1 Constitutive Promoter Activity and Aromatase Basal Expression
por: Ghosh, Sagar, et al.
Publicado: (2008)

Tyrosine phosphorylation regulates ERβ ubiquitination, protein turnover, and inhibition of breast cancer
por: Yuan, Bin, et al.
Publicado: (2016)

Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis
por: Zhang, Xiaowen, et al.
Publicado: (2017)

Transcriptional signature of lymphoblastoid cell lines of BRCA1, BRCA2 and non-BRCA1/2 high risk breast cancer families
por: Pouliot, Marie-Christine, et al.
Publicado: (2017)

An in-depth exploration of the post-test informational needs of BRCA1 and BRCA2 pathogenic variant carriers in Asia
por: Yuen, Jeanette, et al.
Publicado: (2020)

Expression of BRCA1 and ERCC1 as predictive clinical outcome after radiochemotherapy in patients with locoregionally moderate-advanced nasopharyngeal carcinoma
por: Xu, Shan, et al.
Publicado: (2017)

Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide
por: Chai, Kit Man, et al.
Publicado: (2014)

Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Odén, Lovisa, et al.
Publicado: (2016)

BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
por: Purnomosari, Dewajani, et al.
Publicado: (2007)

BRCA1 missense polymorphisms are associated with poor prognosis of pancreatic cancer patients in a Chinese population
por: Zhu, Ying, et al.
Publicado: (2017)

Author Correction: Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis
por: Zhang, Xiaowen, et al.
Publicado: (2018)

Performance of multiplicom's BRCA MASTR Dx kit on the detection of BRCA1 and BRCA2 mutations in fresh frozen ovarian and breast tumor samples
por: Badoer, Cindy, et al.
Publicado: (2016)

Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2019)

Plasma RANKL levels are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Zaman, Tasnim, et al.
Publicado: (2019)

Molecular insights into the OGG1 gene, a cancer risk modifier in BRCA1 and BRCA2 mutations carriers
por: Benitez-Buelga, Carlos, et al.
Publicado: (2016)

The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer
por: Luo, Jiayan, et al.
Publicado: (2016)

Genetic evaluation of BRCA1-A complex genes with triple-negative breast cancer susceptibility in Chinese women
por: Ling, Hong, et al.
Publicado: (2016)

Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis
por: Wang, Ziliang, et al.
Publicado: (2015)

A Phosphotyrosine Switch in Estrogen Receptor β Is Required for Mouse Ovarian Function
por: Yuan, Bin, et al.
Publicado: (2021)

G-Quadruplex Matters in Tissue-Specific Tumorigenesis by BRCA1 Deficiency
por: Kim, Sanghyun, et al.
Publicado: (2022)

Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer
por: Chen, Bo, et al.
Publicado: (2020)

The PARP-1 inhibitor Olaparib suppresses BRCA1 protein levels, increases apoptosis and causes radiation hypersensitivity in BRCA1(+/-) lymphoblastoid cells
por: Bourton, Emma C., et al.
Publicado: (2017)

BRCA1/p220 loss triggers BRCA1-IRIS overexpression via mRNA stabilization in breast cancer cells
por: Shimizu, Yoshiko, et al.
Publicado: (2012)

Validation and optimization of the Ion Torrent S5 XL sequencer and Oncomine workflow for BRCA1 and BRCA2 genetic testing
por: Shin, Saeam, et al.
Publicado: (2017)

The role of Rak in the regulation of stability and function of BRCA1
por: Kim, Jung-Lye, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_si0i67js6ci3m94f5lbbi2mp5b